Don’t miss the latest developments in business and finance.

USFDA Approves Lung Cancer Drug

Glenmark Pharma gets USFDA approval for generic lung cancer drug

Glenmark Pharmaceuticals said it has received approval from the US health regulator to market Nintedanib capsules, used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer

Updated On: 25 Jun 2021 | 12:36 PM IST

USFDA approves AstraZeneca's combo treatment for lung cancer patients

The combo treatment has been approved in the United States for adult patients with extensive-stage small cell lung cancer, the company said

Updated On: 30 Mar 2020 | 3:13 PM IST

AstraZeneca's immunotherapy drug gets US FDA nod for lung cancer treatment

US FDA granted approval for expanded use of Imfinzi to treat non-small cell lung cancer patients

Updated On: 17 Feb 2018 | 11:20 PM IST